{"database": "lobbying", "table": "lobbying_activities", "rows": [[1624150, "9af09abb-ed74-4cc4-aa13-5bbccd7aa319", "4T", "CROSSROADS STRATEGIES, LLC", 400531586, "LUMARA HEALTH", 2014, "fourth_quarter", "PHA", "Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 1, "2015-01-16T11:08:06.767000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1624150"], "units": {}, "query_ms": 20.358645007945597, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}